On Monday, the FDA will say if the pharma’s osteoporosis drug has more pros than cons.
Informa: forbes.com/markets/2008/09/04/pfizer-ligand-closer-mark
4 de Septiembre del 2008 23:34:53 Por: Anita Broker
Categorías: Forbes: Markets News
On Monday, the FDA will say if the pharma’s osteoporosis drug has more pros than cons.
Informa: forbes.com/markets/2008/09/04/pfizer-ligand-closer-mark